Total Investments

$15.37B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Total Investments

Latest reported$15.37Bperiod endingJun 30, 2026

REGN Quarterly Total Investments ($0.00 → $15.37B)

Quarterly total investments

High-resolution chart · PNG

REGN total investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Investments — Quarterly (USD)
Period ending	Total Investments (USD)
Jun 30, 2026	15,367,000,000
Mar 31, 2026	15,577,100,000
Dec 31, 2025	15,747,700,000
Sep 30, 2025	16,222,900,000
Jun 30, 2025	15,532,000,000
Mar 31, 2025	14,535,500,000
Dec 31, 2024	15,424,400,000
Sep 30, 2024	16,275,600,000
Jun 30, 2024	15,610,700,000
Mar 31, 2024	14,896,300,000
Dec 31, 2023	13,511,300,000
Sep 30, 2023	13,539,800,000
Jun 30, 2023	13,317,700,000
Mar 31, 2023	11,110,000,000
Dec 31, 2022	11,228,200,000
Sep 30, 2022	9,499,000,000
Jun 30, 2022	10,587,200,000
Mar 31, 2022	10,788,900,000
Dec 31, 2021	9,647,100,000
Sep 30, 2021	7,986,500,000
Jun 30, 2021	5,738,900,000
Mar 31, 2021	5,609,600,000
Dec 31, 2020	4,528,900,000
Sep 30, 2020	4,328,000,000
Jun 30, 2020	3,739,600,000
Mar 31, 2020	5,031,600,000
Dec 31, 2019	4,853,300,000
Sep 30, 2019	4,605,700,000
Jun 30, 2019	4,508,800,000
Mar 31, 2019	3,863,700,000
Dec 31, 2018	3,097,200,000
Sep 30, 2018	2,977,878,000
Jun 30, 2018	2,810,345,000
Mar 31, 2018	2,427,446,000
Dec 31, 2017	2,083,300,000
Sep 30, 2017	1,914,182,000
Jun 30, 2017	1,588,214,000
Mar 31, 2017	1,463,006,000
Dec 31, 2016	1,367,741,000
Sep 30, 2016	1,265,938,000
Jun 30, 2016	988,508,000
Mar 31, 2016	800,175,000
Dec 31, 2015	868,283,000
Sep 30, 2015	922,381,000
Jun 30, 2015	803,289,000
Mar 31, 2015	717,562,000
Dec 31, 2014	711,915,000
Sep 30, 2014	849,093,000
Jun 30, 2014	767,592,000
Mar 31, 2014	720,964,000
Dec 31, 2013	548,267,000
Sep 30, 2013	511,975,000
Jun 30, 2013	329,159,000
Mar 31, 2013	473,955,000
Dec 31, 2012	349,049,000
Sep 30, 2012	456,154,000
Jun 30, 2012	417,400,000
Mar 31, 2012	292,451,000
Dec 31, 2011	319,219,000
Sep 30, 2011	297,176,000
Jun 30, 2011	306,627,000
Mar 31, 2011	464,686,000
Dec 31, 2010	506,849,000
Sep 30, 2010	191,723,000
Jun 30, 2010	264,802,000
Mar 31, 2010	294,606,000
Dec 31, 2009	181,335,000
Sep 30, 2009	186,675,000
Jun 30, 2009	193,297,000
Mar 31, 2009	295,245,000
Dec 31, 2008	278,015,000
Sep 30, 2008	348,924,000
Jun 30, 2008	408,275,000
Mar 31, 2008	222,373,000
Dec 31, 2007	345,754,000
Sep 30, 2007	299,566,000
Jun 30, 2007	351,054,000
Mar 31, 2007	295,910,000
Dec 31, 2006	221,400,000
Sep 30, 2006	94,227,000
Jun 30, 2006	158,616,000
Mar 31, 2006	120,061,000
Dec 31, 2005	114,037,000
Sep 30, 2005	131,449,000
Jun 30, 2005	190,612,000
Mar 31, 2005	206,090,000
Dec 31, 2004	194,748,000
Sep 30, 2004	173,668,000
Jun 30, 2004	221,217,000
Mar 31, 2004	146,702,000
Dec 31, 2003	175,489,000
Sep 30, 2003	86,056,000
Jun 30, 2003	144,215,000
Mar 31, 2003	120,404,000
Dec 31, 2002	184,194,000
Sep 30, 2002	224,317,000
Jun 30, 2002	229,331,000
Mar 31, 2002	189,601,000
Dec 31, 2001	137,686,000
Sep 30, 2001	140,735,000